Physician profile
Joshuea Cameron
NPI 1154771657
$13,194.22
in general payments reported to CMS, 2019-2025
12 companies · $2,692 in 2025
The $2,692 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.29 · 2021: $162 · 2022: $2,281 · 2023: $4,444 · 2024: $3,576 · 2025: $2,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,435 · Travel and Lodging: $5,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,434.59 |
| Travel and Lodging | $5,277.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,574.12 | 2019-2025 | Mako, Triathlon, Insignia |
| Encore Medical, LP | $3,023.06 | 2022-2023 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $1,009.63 | 2022-2025 | Persona, Activbraid |
| Orthalign INC | $458.08 | 2022-2025 | Orthalign Plus |
| Medical Device Business Services, INC. | $413.60 | 2025 | Velys, Actis, Emphasys |
| Smith+Nephew, INC. | $174.08 | 2021-2022 | |
| Globus Medical, INC. | $128.53 | 2025 | Harvest |
| Wishbone Medical INC. | $118.31 | 2023 | |
| Kci USA, INC. | $107.29 | 2023 | V.A.C. Veraflo |
| Heron Therapeutics, INC. | $100.80 | 2025 | Zynrelef |
| Depuy Synthes Sales INC. | $52.16 | 2021 | |
| Heraeus Medical, LLC. | $34.56 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshuea Cameron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.